Concepedia

Janet Clarke

JC

11

Publications

915

Citations

11

H-Index

1992

Active since

Affiliations

Biogen (United States)(Current)

Sunesis (United States)

Amgen (United States)

University of Liverpool

Covance (United States)

Janet Clarke is an author at Biogen (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1992–2019

11

Publications

11

Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab

Camellia Adams, David E. Allison, Kelly M. Flagella et al. · Cancer Immunology Immunotherapy · 2005 · 312 citations · Full text

, , +6

Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation

Conor Mallucci, Michael D. Jenkinson, Elizabeth J. Conroy et al. · The Lancet · 2019 · 153 citations · Full text

The mechanism of bioactivation and antigen formation of amodiaquine in the rat

Anthony Harrison, Neil R. Kitteringham, Janet Clarke et al. · Biochemical Pharmacology · 1992 · 104 citations

, , +2

Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibody

Janet Clarke, Will Leach, Susanne Pippig et al. · Regulatory Toxicology and Pharmacology · 2004 · 76 citations

, , +11

Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor

Nancy Wehner, George M. Shopp, Ingrid Osterburg et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2009 · 58 citations

Rows per page

1–5 of 11